Literature DB >> 23925559

The effect of levothyroxine replacement therapy on lipid profile and oxidative stress parameters in patients with subclinical hypothyroid.

Serkan Mutlu1, Adem Parlak2, Umit Aydogan3, Aydogan Aydogdu4, Bugra Soykut5, Cemal Akay5, Kenan Saglam6, Abdullah Taslipinar4.   

Abstract

The purpose of this present study is to investigate the levels of oxidative stress parameters in patients with subclinical hypothyroidism (SH) and the effects of levothyroxine (LT4) replacement therapy on these parameters and lipid profile. At the beginning of the study blood samples were collected from the patients in order to analyse oxidative stress parameters, lipid profile and biochemical markers. After replacement therapy with LT4, in the third month, same tests were performed again. At the baseline superoxide dismutase (SOD) levels were found to be higher in SH patients, compared to the euthyroid group. After LT4 therapy, statistically significant decreases in SOD and catalase levels and increase in HDL-C levels were noticed. LT4 treatment was found to have positive effects on oxidative stress indicators and HDL-C levels.
© 2013. The Pharmaceutical Society of Korea.

Entities:  

Keywords:  CAT; Levothyroxine; Lipid; Oxidative stress; SOD; Subclinical hypothyroidism

Mesh:

Substances:

Year:  2013        PMID: 23925559     DOI: 10.1007/s12272-013-0227-y

Source DB:  PubMed          Journal:  Arch Pharm Res        ISSN: 0253-6269            Impact factor:   4.946


  37 in total

Review 1.  When to treat mild hypothyroidism.

Authors:  A R Ayala; M D Danese; P W Ladenson
Journal:  Endocrinol Metab Clin North Am       Date:  2000-06       Impact factor: 4.741

2.  Metabolic effects of liothyronine therapy in hypothyroidism: a randomized, double-blind, crossover trial of liothyronine versus levothyroxine.

Authors:  Francesco S Celi; Marina Zemskova; Joyce D Linderman; Sheila Smith; Bart Drinkard; Vandana Sachdev; Monica C Skarulis; Merel Kozlosky; Gyorgy Csako; Rene Costello; Frank Pucino
Journal:  J Clin Endocrinol Metab       Date:  2011-08-24       Impact factor: 5.958

3.  Evaluation of oxidative stress, the activities of paraoxonase and arylesterase in patients with subclinic hypothyroidism.

Authors:  Egemen Cebeci; Fatma Alibaz Oner; Murat Usta; Selen Yurdakul; Mecdi Erguney
Journal:  Acta Biomed       Date:  2011-12

4.  Thyroid hormone-induced haemoglobin changes and antioxidant enzymes response in erythrocytes.

Authors:  A S R Araujo; F E R Seibel; U O Oliveira; T Fernandes; S Llesuy; L Kucharski; A Belló-Klein
Journal:  Cell Biochem Funct       Date:  2011-05-16       Impact factor: 3.685

5.  Evaluation of oxidative stress, the activities of paraoxonase and arylesterase in patients with subclinical hypothyroidism.

Authors:  Egemen Cebeci; Fatma Alibaz-Oner; Murat Usta; Selen Yurdakul; Mecdi Erguney
Journal:  J Investig Med       Date:  2012-01       Impact factor: 2.895

Review 6.  The clinical significance of subclinical thyroid dysfunction.

Authors:  Bernadette Biondi; David S Cooper
Journal:  Endocr Rev       Date:  2007-11-08       Impact factor: 19.871

Review 7.  Raising high-density lipoprotein cholesterol with reduction of cardiovascular risk: the role of nicotinic acid--a position paper developed by the European Consensus Panel on HDL-C.

Authors:  M John Chapman; Gerd Assmann; Jean-Charles Fruchart; James Shepherd; Cesare Sirtori
Journal:  Curr Med Res Opin       Date:  2004-08       Impact factor: 2.580

8.  The association between TSH within the reference range and serum lipid concentrations in a population-based study. The HUNT Study.

Authors:  Bjørn O Asvold; Lars J Vatten; Tom I L Nilsen; Trine Bjøro
Journal:  Eur J Endocrinol       Date:  2007-02       Impact factor: 6.664

9.  The secondary dyslipidemia and deranged serum phosphate concentration in thyroid disorders.

Authors:  A A Al-Tonsi; A A Abdel-Gayoum; M Saad
Journal:  Exp Mol Pathol       Date:  2004-04       Impact factor: 3.362

10.  Hemostatic system as a risk factor for cardiovascular disease in women with subclinical hypothyroidism.

Authors:  Zeynep Cantürk; Berrin Cetinarslan; Ilhan Tarkun; Nuh Zafer Cantürk; Meltem Ozden; Can Duman
Journal:  Thyroid       Date:  2003-10       Impact factor: 6.568

View more
  4 in total

1.  Association between plasma homocysteine status and hypothyroidism: a meta-analysis.

Authors:  Yande Zhou; Yufang Chen; Xueqin Cao; Chunfeng Liu; Ying Xie
Journal:  Int J Clin Exp Med       Date:  2014-11-15

2.  The effect of L-thyroxine substitution on oxidative stress in early-stage diabetic nephropathy patients with subclinical hypothyroidism: a randomized double-blind and placebo-controlled study.

Authors:  Yong Chen; Ganlin Wu; Meirong Xu
Journal:  Int Urol Nephrol       Date:  2017-12-01       Impact factor: 2.370

3.  Insulin resistance in hypothyroid patients under Levothyroxine therapy: a comparison between those with and without thyroid autoimmunity.

Authors:  Tina Mazaheri; Faranak Sharifi; Koorosh Kamali
Journal:  J Diabetes Metab Disord       Date:  2014-10-30

4.  LDL in patients with subclinical hypothyroidism shows increased lipid peroxidation.

Authors:  Kexi Zha; Changting Zuo; Aihong Wang; Bingchang Zhang; Yan Zhang; Bei Wang; Yunjia Wang; Jiajun Zhao; Ling Gao; Chao Xu
Journal:  Lipids Health Dis       Date:  2015-08-25       Impact factor: 3.876

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.